MAP1LC3A and depressive symptom measurement: Additionally, this SSRI alleviated depression-like symptoms by increasing LC3 (Microtubule-associated protein 1A/1B-light chain 3) expression and autophagosome formation in the hippocampus, which promoted impaired mitochondrial clearance.